REGN - REGENERON PHARMACEUTICALS, INC.
IEX Last Trade
693.695
-1.080 -0.156%
Share volume: 55,468
Last Updated: Fri 10 Jan 2025 08:30:11 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.49%
PREVIOUS CLOSE
CHG
CHG%
$694.78
-1.08
-0.16%
View ratios
| Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2023-05-04 | 2023-08-03 | 2023-11-02 | 2024-02-05 | 2024-05-02 | 2024-08-01 | 2024-10-31 | |
| Cash flow financing | -322.500 M | -614.200 M | -407.300 M | -446.100 M | 47.100 M | -478.100 M | -634.000 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | -120.200 M | |
| Cash flow | 1.368 B | 1.022 B | 1.114 B | 1.090 B | 1.513 B | 354.000 M | 82.800 M | |
| Net income | 817.800 M | 968.400 M | 1.008 B | 1.160 B | 722.000 M | 1.432 B | 1.341 B | |
| Depreciation | 99.500 M | 103.100 M | 105.400 M | 113.000 M | 114.100 M | 120.700 M | 121.700 M | |
| Changes in inventories | 2.425 B | 2.508 B | 2.562 B | 2.581 B | 2.715 B | 2.874 B | 0.000 | |
| Changes in receivables | 5.119 B | 5.121 B | 5.585 B | 5.667 B | 5.222 B | 5.717 B | 0.000 | |
| Investing Cashflow | -235.700 M | -2.387 B | -496.300 M | -66.200 M | -1.687 B | -557.200 M | -574.400 M | |
| Net Borrowings | -6.664 B | -6.592 B | -7.786 B | -8.529 B | -8.231 B | -7.787 B | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -178.200 M | -113.000 M | -176.000 M | -251.400 M | -133.900 M | -180.500 M | 241.900 M | |
| Cash Change | 8.960 B | 8.928 B | 9.914 B | 10.845 B | 10.520 B | 9.809 B | 83.600 M |